This inventor holds 3 USPTO granted patents. Top assignees: Kunming University of Science and Technology, Hohai University, Huaneng Group R&D Center Co., Ltd.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 80 
1 out of 85 
1 out of 2 Years Active: 2022-2026
Title: Min Xu: Innovator in Antiviral Drug Development
Introduction
Min Xu is a prominent inventor based in Kunming, China. He has made significant contributions to the field of antiviral drug development, holding 3 patents that focus on innovative sesquiterpenoid derivatives. His work aims to address various viral infectious diseases, including those caused by the hepatitis B virus and other significant pathogens.
Latest Patents
Min Xu's latest patents include a sesquiterpenoid derivative that is utilized in preparing a broad-spectrum antiviral drug. This derivative has the capability to stimulate heterogeneous nuclear ribonucleoprotein A2/B1, activate the TANK-binding kinase 1-interferon regulatory factor 3 cell signaling pathway, and enhance the expression and secretion of endogenous type I interferon. As a result, it can inhibit a wide range of viruses, making it a potential treatment for various viral infectious diseases, including Covid-19, hepatitis C, and influenza. Additionally, he has developed a sesquiterpenoid derivative for treating hepatitis B diseases, which down-regulates hepatocyte nuclear factor 4α and significantly inhibits the hepatitis B virus. This derivative can also be formulated into various pharmaceutical preparations, including oral dosage forms and injections.
Career Highlights
Min Xu is affiliated with Kunming University of Science and Technology, where he continues to advance his research in antiviral drug development. His innovative work has positioned him as a key figure in the field, contributing to the understanding and treatment of viral infections.
Collaborations
Min Xu collaborates with notable colleagues, including Shaoxing Dai and Haoyang Yuan, to further enhance the impact of his research and innovations in the pharmaceutical field.
Conclusion
Min Xu's contributions to antiviral drug development through his innovative sesquiterpenoid derivatives highlight his role as a leading inventor in the fight against viral diseases. His work not only advances scientific knowledge but also holds the potential for significant public health benefits.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile